Question 1

What is the catalog number for PAC4 crosslinker?

Accepted Answer

The catalog number for PAC4 crosslinker is orb2645404.

Question 2

What sizes are available for PAC4 crosslinker?

Accepted Answer

PAC4 crosslinker is available in the following size(s): 50 mg, 100 mg.

Question 3

How many pack sizes does PAC4 crosslinker come in?

Accepted Answer

PAC4 crosslinker is available in 2 different pack sizes.

Question 4

Is PAC4 crosslinker in stock?

Accepted Answer

PAC4 crosslinker is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is PAC4 crosslinker used for?

Accepted Answer

PAC4 crosslinker

Question 6

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 7

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 8

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

PAC4 crosslinker

Product Specifications

CAS Number

Form

Smiles

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-RTN4/NOGO Antibody (NG-101)

PDGF-D/SCDGFB Rabbit Polyclonal Antibody (HRP)

SREBF2 Antibody, FITC conjugated

SREBF2 Antibody, FITC conjugated

Recombinant Human CD262/TRAIL-R2/DR5 Protein, C-His (Active)

V6 Anti-Human CCR4 (Mogamulizumab)